Book a free demo
H-1B Data › Employers › Novartis Gene Therapies, Inc.
Check another employer
H-1B Sponsor Profile

Novartis Gene Therapies, Inc. — H-1B Visa Sponsorship Data

32 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.

East Hanover, NJActive FY2021–FY2026Transfer-FriendlyFull-Time RolesNot H-1B Dependent
● Data current through FY2026 · sourced from U.S. DOL OFLC, updated quarterly
Sponsors H-1B?
Yes
32 certified LCAs
FY2026 filings
2
most recent disclosure year
Median H-1B salary
$98,842
typical $82,742–$112,429
H-1B dependent?
No
per the employer's LCA attestation
Transfer share
47%
change-of-employer filings

2 items a DOL auditor would ask Novartis Gene Therapies, Inc. about

Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Novartis Gene Therapies, Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.

1 need attention1 to watch2 clear
Needs attention
100% of LCAs offer a wage within 2% of the prevailing wage

Median offered wage is 0% above the DOL prevailing wage across 3 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.

Auditor asksShow the actual wage paid (payroll) matches or exceeds the LCA wage for every worker, including benched time.
In your PAFActual-wage memorandum and pay records per LCA; wage-level rationale where the offered wage equals the PW.
Watch
7 worksites across 5 states

Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.

Auditor asksWhere is the posting record for each worksite, and were short-term placements tracked against the 30/60-day limits?
In your PAFPosting notices (or electronic-notice records) per worksite; new-worksite LCAs; placement log.
Clear
3% of certified LCAs are at Wage Level I

Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.

Auditor asksHow was Level I justified for each role — required education, experience and the actual duties performed?
In your PAFPrevailing-wage determination and wage-level worksheet for every Level I LCA.
Clear
Not H-1B dependent (per LCA attestation)

No additional recruitment or non-displacement attestations apply.

Auditor asksDoes the current H-1B headcount still fall under the dependency threshold?
In your PAFHeadcount snapshot supporting the non-dependent attestation at each filing.
Are you Novartis Gene Therapies, Inc.? Get the private PAF / LCA gap check.
We compare these public filings against what must be in your Public Access Files and send you the gap list — free, within one business day. No platform migration, no commitment.
Get my private gap check →

Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.

For job seekers

Considering a job at Novartis Gene Therapies, Inc.?

Does Novartis Gene Therapies, Inc. sponsor H-1B visas?

Yes — Novartis Gene Therapies, Inc. sponsors H-1B workers, with 32 certified LCAs on file (FY2021–FY2026), including 2 in FY2026. The median certified salary is $98,842 (P25 $82,742, P75 $112,429). With a 47% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.

What to Know Before Applying to Novartis Gene Therapies, Inc.

Salary range
Median $98,842, typical band $82,742–$112,429.
Transfers
47% of filings are transfers — this employer has an established H-1B transfer track record.
Typical locations
Durham, NC, Libertyville, IL, Bannockburn, IL, North Royalton, OH.
Position type
100% of filings are full-time roles.
Common roles
Associate Director, Regions Global Reg, Business Systems Analyst 2, Manufacturing Quality Assurance Specia.
Benchmark this employer in the H-1B database →
Looking for your next role?
See open positions on ElevateRecruit, the ElevateStaffing job board.
Browse open jobs →

Frequently asked questions

Yes. Novartis Gene Therapies, Inc. has 32 certified Labor Condition Applications (LCAs) on file with the U.S. Department of Labor (FY2021–FY2026).

The median sponsored salary is $98,842, with a typical P25–P75 band of $82,742–$112,429 across certified LCAs.

Yes — 47% of its LCA filings are change-of-employer (transfer) cases, indicating an active transfer pipeline.

No — the employer attests it is not H-1B dependent on its LCA filings.

Novartis Gene Therapies, Inc. filed 2 certified LCAs in FY2026, the most recent fiscal year of U.S. DOL disclosure data.

Top worksites include Durham, NC, Libertyville, IL, Bannockburn, IL, North Royalton, OH.
Sponsorship data

Novartis Gene Therapies, Inc. H-1B data at a glance

Executive Summary

Novartis Gene Therapies, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).

  • Median certified salary is $98,842, typically $82,742–$112,429 (P25–P75).
  • 100% of certified filings are at or above the DOL prevailing wage.
  • Change-of-employer (transfer) share is 47% — workers actively transfer to this employer.
  • Worksite footprint spans 5 states and 7 cities.
  • Most-sponsored roles: Associate Director, Regions Global Regul, Business Systems Analyst 2, Manufacturing Quality Assurance Speciali.
  • Filed 2 certified LCAs in FY2026, the most recent disclosure year.

Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.

Salary Distribution

$63,856
$169,542
P25$82,742
Median$98,842
P75$112,429

The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.

100% of certified filings at or above the DOL prevailing wage.

Wage Level Distribution

Level I
3%
Level II
38%
Level III
21%
Level IV
38%

Levels I–IV are DOL prevailing-wage experience tiers; 59% of filings are senior-level (III–IV).

Filing history

LCA filings by fiscal year

Certified LCAs per year

FY2021
12
FY2022
6
FY2023
8
FY2025
4
FY2026
2
Fiscal yearCertifiedDeniedWithdrawnTotal
FY2021120012
FY20226006
FY20238008
FY20254004
FY20262002

Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.

See a single year in detail:
FY2021 ›FY2022 ›FY2023 ›FY2025 ›FY2026 ›

All LCA filings

11 filings
Job titleSalaryLevelLocationFiledStatus
Specialist, Quality Control
I-200-25150-034310
$84,344/yrIDurham, NCMay 30, 2025Certified
Specialist, Quality Control IT
I-200-25119-918670
$112,320/yrIIDurham, NCApr 29, 2025Certified
Senior Specialist, Quality Assurance
I-200-24284-400018
$92,206/yrIIIDurham, NCOct 10, 2024Certified
Senior Project Manager, Manufacturing Science and Technology
I-200-22112-097122
$100,838/yrIVDurham, NCApr 22, 2022Certified
Quality Control Microbiology Supervisor
I-200-22104-071346
$154,856/yrIVDurham, NCApr 14, 2022Certified
Business Systems Analyst
I-200-21106-231938
$79,747/yrIIDeerfield, ILApr 16, 2021Certified
Process Science Engineer III
I-200-21089-184677
$83,741/yrIISan Diego, CAMar 30, 2021Certified
Senior Project Manager, Manufacturing Science and Technology
I-200-21083-170718
$103,646/yrIVDurham, NCMar 24, 2021Certified
Manufacturing Quality Associate
I-200-21060-110457
$63,856/yrIILibertyville, ILMar 01, 2021Certified
Associate Director, Regions Global Regulatory Affairs
I-200-20345-949455
$169,542/yr—Bannockburn, ILDec 10, 2020Certified
Business Systems Analyst 2
I-200-20346-952027
$96,054/yrIVNorth Royalton, OHDec 10, 2020Certified

One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.

Every certified LCA needs its own Public Access File. Get the private gap check →
Sponsorship insights

How Novartis Gene Therapies, Inc. sponsors H-1B talent

Petition Mix

New employment  22%Transfer (change of employer)  47%Continued employment  28%Amendments & other  3%
High transfer share (47%) — H-1B workers actively change employers to join Novartis Gene Therapies, Inc..

Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.

Filing Activity by Month

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Most active filing months: Mar and Dec — useful for timing transfer conversations.

Compliance Posture

H-1B Dependent
No
Willful Violator
No
Full-Time Positions
100%
At/Above Prevailing Wage
100%

Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.

Roles & geography

Top sponsored roles & worksites

Top job titles

Associate Director, Regions Global
3 · $169,542
Business Systems Analyst 2
3 · $96,054
Manufacturing Quality Assurance Sp
3 · $85,322
Senior Project Manager, Manufactur
3 · $102,710
Specialist, Quality Control
3 · $100,748

Top worksite locations

5 states · 7 cities

Durham, NC
17
Libertyville, IL
6
Bannockburn, IL
3
North Royalton, OH
3
Deerfield, IL
1
ElevateStaffing.ai Platform

Built for H-1B compliance teams

The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:

LCA & Public Access Files
Track every Labor Condition Application and auto-assemble the Public Access File within the DOL's 1-business-day window.
I-9 & E-Verify
Centralize I-9s and E-Verify status with automatic alerts before any work authorization lapses.
Visa & I-983 deadlines
Never miss an H-1B extension, EAD renewal, or STEM OPT I-983 evaluation — every deadline is tracked and alerted.
Audit & site-visit ready
FDNS site-visit and USCIS audit ready: every LCA posting, wage memo and document in one timestamped vault.
Explore more

Similar H-1B sponsors by filing volume

Sponsor H-1B talent? Know your gaps before an auditor does.

Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.

Get my private gap check →
Novartis Gene Therapies, Inc. · audit readiness
1 need attention1 to watch2 clear
Get my private gap check →